[ Ссылка ]
Technology has accelerated the pace of innovation and this presents significant opportunities to help promote longer, healthier and more fulfilled lives. A number of technologies and innovations have the potential to shape the future of humanity over the next decade. The use robots in social care, the application of artificial intelligence in healthcare, the role of gene editing to eliminate disease and the rise of super intelligence as we witness the merging of humans and machines will present both opportunities and challenges. The panel will debate the optimal governance framework required to ensure that these technologies and innovations can help society fulfill its potential rather than creating inequality.
Camilla Cavendish
Camilla Cavendish is an award-winning journalist and broadcaster, and the author of “Extra Time: Ten Lessons for an Ageing World”, published by HarperCollins in 2019. She is a Senior Fellow at Harvard’s Kennedy School. She is also Contributing Editor at the Financial Times where she writes a weekly op-ed column on Saturdays.
Camilla was Head of the Prime Minister’s UK Policy Unit under David Cameron. One of the policies associated with her is the 2016 “sugar tax” on fizzy drinks. She has been a Non-Executive Director of the Care Quality Commission, and was author of the 2013 Cavendish Review, an independent review for the Department of Health, into junior nursing staff and care workers. She now sits in the House of Lords as a non-aligned peer: Baroness Cavendish of Little Venice.
Stephen Emmott
Stephen is a scientist and entrepreneur with a track record of scientific leadership and technological innovation in some of the world’s leading technology companies. He is Founder and CEO of Scientific, a technology business which operates at the intersection of science, technology and impact investment innovation.
From 2003 to 2016, Stephen was Chief Scientist and Global Head of Computational Science at Microsoft, where he led Microsoft’s Computational Science Laboratory in Cambridge, pioneering new kinds of science to develop previously impossible, game-changing solutions to this century’s greatest challenges and opportunities. Prior to that, Stephen and was Chief Scientist, NCR Corporation's Advanced Research Lab. Stephen started his career as a postdoctoral scientist at Bell Laboratories, under Nobel Laureate Arno Penzias.
Dafina Grapci-Penney (moderator)
Dafina Grapci-Penney is a Trustee of The Longevity Forum. She is also a Managing Director at Greentarget, a communications consultancy advising global financial institutions and corporates.
James Lawford-Davies
James is a solicitor and partner at Hill Dickinson in London. He specialises in life sciences regulation and litigation with a particular interest in cell and gene therapies. He advises a large number of companies, clinics, and universities regulated by the MHRA, HFEA and HTA, and has been involved in most of the leading cases relating to reproductive and genetic technologies in the UK. He advised the Francis Crick Institute in relation to their successful application to use germline genome editing in human embryos, the first such regulatory approval of its kind in the world. In addition, he advised the Wellcome Trust and Newcastle University in relation to mitochondrial donation, both as a research project and therapy, and in relation to the successful passage of the draft Human Fertilisation and Embryology (Mitochondrial Donation) Regulations 2015 (a similar route to that required to allow the use of genome editing in therapy).
James was previously a lecturer at the Institute of Human Genetics at the University of Newcastle, a Visiting Research Fellow at Durham University Law School, and is now an Honorary Lecturer in the Department of Biochemical Engineering at UCL.
Ali Parsa
Dr Ali Parsa is a British-Iranian healthcare entrepreneur and engineer. He’s the founder and CEO of Babylon, the revolutionary AI and digital health company. Babylon’s mission is to put an accessible and affordable health service in the hands of every person on earth.
Dr Parsa was listed in The Times 100 people to watch. The Health Service Journal recognised him as one of ‘the 50 most influential people in UK healthcare’. He was featured in the Maserati 100, a list that recognises game-changing entrepreneurs. He’s a UK Cabinet Office Ambassador for Mutuals and has a PhD in Engineering Physics.
Anders Sandberg
Anders’ research at the Future of Humanity Institute centres on management of low-probability high-impact risks, estimating the capabilities of future technologies, and very long-range futures. Anders is a Senior Research Fellow on the ERC UnPrEDICT Programme and the FHI-Amlin Collaboration. He is research associate to the Oxford Uehiro Centre for Practical Ethics, and the Oxford Centre for Neuroethics.
